Skip to main content

Table 2 Lipids, apolipoproteins and atherogenic indices of the study groups

From: Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study

 

CRF

HD

PD

TG (mmol.L-1)

3.11 ± 0.4

1.48 ± 0.62**

1.7 ± 0.42**

TC (mmol.L-1)

6.02 ± 2.48

6.82 ± 1.29

4.7 ± 1.57 #

HDL-C (mmol.L-1)

1.29 ± 0.94

1.09 ± 0.41

1.07 ± 0.53

LDL-C (mmol.L-1)

2.25 ± 0.62

3.76 ± 0.27**#

2.35 ± 0.40

Apo A-I (g. L-1)

1.07 ± 0.53

1.11 ± 0.14

0.89 ± 0.48

Apo B (g. L-1)

0.34 ± 0.05

0.27 ± 0.07

0.30 ± 0.04

TC/HDL-C

7.38 ± 0.34

4.88 ± 0.73 *

2.27 ± 0.48**###

LDL-C/HDL-C

2.50 ± 0.94

2.96 ± 0.35

2.59 ± 1.36

Apo AI/Apo B

2.43 ± 0.85

3.89 ± 0.67

3.04 ± 1.75

  1. CRF: End stage chronic renal failure patients. HD: patients on hemodialysis. PD: Patients on peritoneal dialysis. Data are presented as the mean ± SD. HD group and PD group vs CRF group # HD group vs PD group. *# (P < 0.05); **##(P < 0.01); ###(P < 0.001)